These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 28068319)

  • 1. FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation.
    Zhou H; Liu Y; Zhu R; Ding F; Wan Y; Li Y; Liu Z
    Oncogene; 2017 Jun; 36(23):3312-3321. PubMed ID: 28068319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FBXO32 Targets c-Myc for Proteasomal Degradation and Inhibits c-Myc Activity.
    Mei Z; Zhang D; Hu B; Wang J; Shen X; Xiao W
    J Biol Chem; 2015 Jun; 290(26):16202-14. PubMed ID: 25944903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of F-box protein atrogin-1 is regulated by p38 mitogen-activated protein kinase pathway in cardiac H9c2 cells.
    Li JJ; Zhang TP; Meng Y; Du J; Li HH
    Cell Physiol Biochem; 2011; 27(5):463-70. PubMed ID: 21691063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Fbw7 tumor suppressor targets KLF5 for ubiquitin-mediated degradation and suppresses breast cell proliferation.
    Zhao D; Zheng HQ; Zhou Z; Chen C
    Cancer Res; 2010 Jun; 70(11):4728-38. PubMed ID: 20484041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endophilin-A Deficiency Induces the Foxo3a-Fbxo32 Network in the Brain and Causes Dysregulation of Autophagy and the Ubiquitin-Proteasome System.
    Murdoch JD; Rostosky CM; Gowrisankaran S; Arora AS; Soukup SF; Vidal R; Capece V; Freytag S; Fischer A; Verstreken P; Bonn S; Raimundo N; Milosevic I
    Cell Rep; 2016 Oct; 17(4):1071-1086. PubMed ID: 27720640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stratifin Inhibits SCF
    Shiba-Ishii A; Hong J; Hirokawa T; Kim Y; Nakagawa T; Sakashita S; Sakamoto N; Kozuma Y; Sato Y; Noguchi M
    Clin Cancer Res; 2019 May; 25(9):2809-2820. PubMed ID: 30728155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FBXO32 activates NF-κB through IκBα degradation in inflammatory and genotoxic stress.
    Meshram SN; Paul D; Manne R; Choppara S; Sankaran G; Agrawal Y; Santra MK
    Int J Biochem Cell Biol; 2017 Nov; 92():134-140. PubMed ID: 28970077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tumor suppressor ING3 is degraded by SCF(Skp2)-mediated ubiquitin-proteasome system.
    Chen G; Wang Y; Garate M; Zhou J; Li G
    Oncogene; 2010 Mar; 29(10):1498-508. PubMed ID: 19935701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TSGΔ154-1054 splice variant increases TSG101 oncogenicity by inhibiting its E3-ligase-mediated proteasomal degradation.
    Chua HH; Huang CS; Weng PL; Yeh TH
    Oncotarget; 2016 Feb; 7(7):8240-52. PubMed ID: 26811492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical lysine residues of Klf4 required for protein stabilization and degradation.
    Lim KH; Kim SR; Ramakrishna S; Baek KH
    Biochem Biophys Res Commun; 2014 Jan; 443(4):1206-10. PubMed ID: 24388984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Destabilization of Krüppel-like factor 4 protein in response to serum stimulation involves the ubiquitin-proteasome pathway.
    Chen ZY; Wang X; Zhou Y; Offner G; Tseng CC
    Cancer Res; 2005 Nov; 65(22):10394-400. PubMed ID: 16288030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired platinum resistance involves epithelial to mesenchymal transition through ubiquitin ligase FBXO32 dysregulation.
    Tanaka N; Kosaka T; Miyazaki Y; Mikami S; Niwa N; Otsuka Y; Minamishima YA; Mizuno R; Kikuchi E; Miyajima A; Sabe H; Okada Y; Uhlén P; Suematsu M; Oya M
    JCI Insight; 2016 Nov; 1(18):e83654. PubMed ID: 27812537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TAZ antagonizes the WWP1-mediated KLF5 degradation and promotes breast cell proliferation and tumorigenesis.
    Zhao D; Zhi X; Zhou Z; Chen C
    Carcinogenesis; 2012 Jan; 33(1):59-67. PubMed ID: 22045023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteasomal degradation of the KLF5 transcription factor through a ubiquitin-independent pathway.
    Chen C; Zhou Z; Guo P; Dong JT
    FEBS Lett; 2007 Mar; 581(6):1124-30. PubMed ID: 17320083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPSB3 targets SNAIL for degradation in GSK-3β phosphorylation-dependent manner and regulates metastasis.
    Liu Y; Zhou H; Zhu R; Ding F; Li Y; Cao X; Liu Z
    Oncogene; 2018 Feb; 37(6):768-776. PubMed ID: 29059170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KLF4 is regulated by RAS/RAF/MEK/ERK signaling through E2F1 and promotes melanoma cell growth.
    Riverso M; Montagnani V; Stecca B
    Oncogene; 2017 Jun; 36(23):3322-3333. PubMed ID: 28068326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Krüppel-like factor 4 by the anaphase promoting complex pathway is involved in TGF-beta signaling.
    Hu D; Wan Y
    J Biol Chem; 2011 Mar; 286(9):6890-901. PubMed ID: 21177849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SCF
    Choppara S; Ganga S; Manne R; Dutta P; Singh S; Santra MK
    J Biol Chem; 2018 Oct; 293(42):16291-16306. PubMed ID: 30171069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute myelogenous leukemia-derived SMAD4 mutations target the protein to ubiquitin-proteasome degradation.
    Yang L; Wang N; Tang Y; Cao X; Wan M
    Hum Mutat; 2006 Sep; 27(9):897-905. PubMed ID: 16865698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FBW7 regulates endothelial functions by targeting KLF2 for ubiquitination and degradation.
    Wang R; Wang Y; Liu N; Ren C; Jiang C; Zhang K; Yu S; Chen Y; Tang H; Deng Q; Fu C; Wang Y; Li R; Liu M; Pan W; Wang P
    Cell Res; 2013 Jun; 23(6):803-19. PubMed ID: 23507969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.